BiotechTube

LPH-5 + Placebo

Phase 1Recruiting
0 watching 0 views this week๐Ÿ’ค Quiet
25
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Safety Issues

Conditions

Safety Issues, Tolerance

Trial Timeline

Apr 30, 2025 โ†’ Dec 31, 2025

NCT ID
NCT06722820

About LPH-5 + Placebo

LPH-5 + Placebo is a phase 1 stage product being developed by Biotrial for Safety Issues. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06722820. Target conditions include Safety Issues, Tolerance.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT06722820Phase 1Recruiting

Competing Products

20 competing products in Safety Issues

See all competitors
ProductCompanyStageHype Score
DS-1971 + placeboDaiichi SankyoPhase 1
33
ASP7962 + PlaceboAstellas PharmaPhase 1
33
ASP2151 + Valacyclovir + PlaceboAstellas PharmaPhase 1
33
AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solutionAstraZenecaPhase 1
33
Anifrolumab SC injection (300mg) + Anifrolumab IV infusion (300mg) + Anifrolumab SC infusion (600mg) + Anifrolumab placebo SC injection (300mg) + Anifrolumab placebo IV infusion (300mg) + Anifrolumab placebo SC infusion (600mg)AstraZenecaPhase 1
33
AZD7594 + Placebo to matchAstraZenecaPhase 1
33
Anastrozole ODF + Arimidex tablet + Anastrozole ODF + Arimidex tabletAstraZenecaPhase 1
33
AZD4721 Solution + AZD4721 Placebo + AZD4721 SuspensionAstraZenecaPhase 1
33
AZD9977, oral suspension + Placebo, oral suspension + AZD9977, oral solutionAstraZenecaPhase 1
33
AZD3043AstraZenecaPhase 1
33
AZD8848 + Placebo to match AZD8848AstraZenecaPhase 1
33
AZD9567 Monohydrat + Placebo oral suspension/ Placebo capsule + PrednisoloneAstraZenecaPhase 1
33
AZD7503 + PlaceboAstraZenecaPhase 1
33
Fluad + SalineNovartisApproved
85
TBM100NovartisApproved
85
VIB9600 + PlacebosAmgenPhase 1
32
DenosumabAmgenPhase 3
76
Cadonilimab Combined Albumin-paclitaxel, Cisplatin and FluorouracilAkesoPhase 2
51
HTL0018318 + Placebo oral capsuleNxera PharmaPhase 1
32
Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + PlaceboBayerApproved
82

Other Products from Biotrial

EXS21546Phase 1/2
33
Phase 1, SQY51 + Phase 2a, SQY51 (cohort 1) + Phase 2a, SQY51 (cohort 2) + Phase 2a, SQY51 (cohort 3)Phase 1/2
33
Binimetinib Oral TabletPhase 1
25
ITF2357Phase 1
25
VNA-318 + PlaceboPhase 1
25